Insulin replacement therapy in diabetic rats using an osmotic pump normalizes protein and mrna levels of enzymes key to hepatic carbohydrate metabolism

Ken Kramer, B. F. Giffin, J. W. Fox, R. L. Drake

Research output: Contribution to journalArticle

Abstract

In previous studies we demonstrated the failure of hepatic protein and mRNA levels of phosphoenolpyruvate carboxykinase (PEPCK), glycogen synthase (GS) and glycogen phosphorylase (GP) to return to control levels in the insulininjected diabetic rat. The purpose of this study was to determine whether these results are a consequence of the insulin replacement therapy or a new homeostasis resulting from the diabetic condition. Alloxan-diabetic rats received similar amounts of insulin for 5 days, either by twice daily injections (TDI) or continuous subcutaneous infusion (CSI) using an Alzet osmotic pump. While TDI brought blood glucose levels within normal limits, there were transient hyperglycémie fluctuations between injections over a 24 hour period. These variations in blood glucose levels were not observed in the CSI animals which were strictly controlled at normal levels. PEPCK, GS and GP protein and mRNA from TDI rats were identical to those previously observed. In contrast, all the aforementioned protein and mRNA levels returned to control levels in CSI-treated animals. This data emphasizes the effects of altered blood glucose levels on hepatic carbohydrate metabolism, and further emphasizes the importance of strictly regulating blood glucose in the treatment of insulin-dependent diabetes.

Original languageEnglish
JournalFASEB Journal
Volume10
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

Carbohydrate Metabolism
carbohydrate metabolism
Subcutaneous Infusions
pumps
blood glucose
glycogen (starch) synthase
Blood Glucose
Rats
Pumps
Insulin
injection
Glycogen Phosphorylase
Glycogen Synthase
liver
Phosphoenolpyruvate
Injections
phosphorylase
Liver
Level control
rats

All Science Journal Classification (ASJC) codes

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Insulin replacement therapy in diabetic rats using an osmotic pump normalizes protein and mrna levels of enzymes key to hepatic carbohydrate metabolism. / Kramer, Ken; Giffin, B. F.; Fox, J. W.; Drake, R. L.

In: FASEB Journal, Vol. 10, No. 3, 1996.

Research output: Contribution to journalArticle

@article{06bd9e4205ff4ece928e7571bf68e50a,
title = "Insulin replacement therapy in diabetic rats using an osmotic pump normalizes protein and mrna levels of enzymes key to hepatic carbohydrate metabolism",
abstract = "In previous studies we demonstrated the failure of hepatic protein and mRNA levels of phosphoenolpyruvate carboxykinase (PEPCK), glycogen synthase (GS) and glycogen phosphorylase (GP) to return to control levels in the insulininjected diabetic rat. The purpose of this study was to determine whether these results are a consequence of the insulin replacement therapy or a new homeostasis resulting from the diabetic condition. Alloxan-diabetic rats received similar amounts of insulin for 5 days, either by twice daily injections (TDI) or continuous subcutaneous infusion (CSI) using an Alzet osmotic pump. While TDI brought blood glucose levels within normal limits, there were transient hyperglyc{\'e}mie fluctuations between injections over a 24 hour period. These variations in blood glucose levels were not observed in the CSI animals which were strictly controlled at normal levels. PEPCK, GS and GP protein and mRNA from TDI rats were identical to those previously observed. In contrast, all the aforementioned protein and mRNA levels returned to control levels in CSI-treated animals. This data emphasizes the effects of altered blood glucose levels on hepatic carbohydrate metabolism, and further emphasizes the importance of strictly regulating blood glucose in the treatment of insulin-dependent diabetes.",
author = "Ken Kramer and Giffin, {B. F.} and Fox, {J. W.} and Drake, {R. L.}",
year = "1996",
language = "English",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Insulin replacement therapy in diabetic rats using an osmotic pump normalizes protein and mrna levels of enzymes key to hepatic carbohydrate metabolism

AU - Kramer, Ken

AU - Giffin, B. F.

AU - Fox, J. W.

AU - Drake, R. L.

PY - 1996

Y1 - 1996

N2 - In previous studies we demonstrated the failure of hepatic protein and mRNA levels of phosphoenolpyruvate carboxykinase (PEPCK), glycogen synthase (GS) and glycogen phosphorylase (GP) to return to control levels in the insulininjected diabetic rat. The purpose of this study was to determine whether these results are a consequence of the insulin replacement therapy or a new homeostasis resulting from the diabetic condition. Alloxan-diabetic rats received similar amounts of insulin for 5 days, either by twice daily injections (TDI) or continuous subcutaneous infusion (CSI) using an Alzet osmotic pump. While TDI brought blood glucose levels within normal limits, there were transient hyperglycémie fluctuations between injections over a 24 hour period. These variations in blood glucose levels were not observed in the CSI animals which were strictly controlled at normal levels. PEPCK, GS and GP protein and mRNA from TDI rats were identical to those previously observed. In contrast, all the aforementioned protein and mRNA levels returned to control levels in CSI-treated animals. This data emphasizes the effects of altered blood glucose levels on hepatic carbohydrate metabolism, and further emphasizes the importance of strictly regulating blood glucose in the treatment of insulin-dependent diabetes.

AB - In previous studies we demonstrated the failure of hepatic protein and mRNA levels of phosphoenolpyruvate carboxykinase (PEPCK), glycogen synthase (GS) and glycogen phosphorylase (GP) to return to control levels in the insulininjected diabetic rat. The purpose of this study was to determine whether these results are a consequence of the insulin replacement therapy or a new homeostasis resulting from the diabetic condition. Alloxan-diabetic rats received similar amounts of insulin for 5 days, either by twice daily injections (TDI) or continuous subcutaneous infusion (CSI) using an Alzet osmotic pump. While TDI brought blood glucose levels within normal limits, there were transient hyperglycémie fluctuations between injections over a 24 hour period. These variations in blood glucose levels were not observed in the CSI animals which were strictly controlled at normal levels. PEPCK, GS and GP protein and mRNA from TDI rats were identical to those previously observed. In contrast, all the aforementioned protein and mRNA levels returned to control levels in CSI-treated animals. This data emphasizes the effects of altered blood glucose levels on hepatic carbohydrate metabolism, and further emphasizes the importance of strictly regulating blood glucose in the treatment of insulin-dependent diabetes.

UR - http://www.scopus.com/inward/record.url?scp=33749124721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749124721&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -